Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

Sea sponges could hold key to new cancer-beating drugs

Post Thumbnail

Researchers funded by a flagship Fife charity believe chemicals found in sea sponges could be “tweaked” to create a new generation of anti-cancer drugs.

Scientist Dr Matthew Fuchter and his team received a £106,079 grant from the St Andrews-based Association for International Cancer Research (AICR).

The experts are using the cash to aid their painstaking investigation of a naturally-occurring chemical found in the sea sponge.

Molecules found in deep sea organisms are already used in research into a number of diseases, including malaria and cancer.

The sea sponge being examined by Dr Fuchter contains the chemical psammaplin A, which is reported to be a powerful blocker of several components of the processing machinery in cancer cells, preventing them from growing and dividing.

Dr Fuchter and his team from Imperial College London have discovered a new way of making psammaplin A which has the potential to inspire novel anti-cancer drugs.

The new route allows the researchers to make variations of the chemical and use the variants to understand the natural product’s anti-cancer activity.

Dr Fuchter’s preliminary results show that his psammaplin A variants are far more potent than nature’s own attempts. As such, they could form the basis of new, selective drugs which could be far more effective in the battle against cancer.

“New chemical routes toward the natural product psammaplin A were developed with the particular view to preparing diverse variants for biological assessment,” Dr Fuchter said

“These routes utilise cheap and commercially available starting materials, and allowed access to psammaplin A variants not accessible via currently reported methods.”

Encouraging preliminary studies have led Dr Fuchter to believe a new range of anti-cancer drugs could be manufactured.

At just 31, Dr Fuchter is the youngest person to receive a grant from the AICR in St Andrews and he said the funding represented a “milestone” in his fledgling career.

“When I got the approval for the grant I was ecstatic. It was a real milestone for a young academic like me.”

Photo used under a Creative Commons licence courtesy of Flickr user Charles Williams.